세계의 혈압계 시장 : 기회, 성장 촉진요인, 산업 동향 분석 예측(2024-2032년)

The Global Sphygmomanometer Market was worth USD 3.4 billion in 2023 and is anticipated to exhibit an 8.5% CAGR from 2024 to 2032, attributed to the rising incidence of cardiac conditions, advancements in technology, and the ongoing launch of innovative products. As hypertension becomes increasingly common, there is a growing demand for accurate and reliable blood pressure monitoring devices. Technological innovations, such as digital sphygmomanometers with automated readings and connectivity features, enhance user experience and data management. Also, ongoing improvements in design and functionality are making these devices more accessible and efficient, further propelling the market's expansion in both clinical and home settings.

The sphygmomanometer industry is segregated based on product, operation, configuration, end-use, and region. The digital sphygmomanometer segment achieved USD 2 billion in 2023, owing to its user-friendly design and enhanced accuracy. Digital devices offer automatic readings, which eliminate manual errors and provide quicker results, making them particularly appealing for both healthcare professionals and home users. The convenience of features such as memory storage, Bluetooth connectivity, and easy-to-read displays further drives their adoption.

As awareness of hypertension management grows, the demand for digital sphygmomanometers is likely to continue rising, solidifying their dominance in the market. The manual sphygmomanometer segment generated USD 1.4 billion in 2023, primarily due to its longstanding reliability and cost-effectiveness. Often favored in clinical settings, manual devices allow healthcare professionals to take precise blood pressure readings through auscultation, ensuring accuracy. They are widely used in hospitals and clinics where training and expertise are readily available.

Besides, manual sphygmomanometers do not require batteries or electricity, making them a practical choice in various environments. This combination of reliability and practicality helps reinforce their position in the market. North America sphygmomanometer market witnessed USD 640.7 million in 2023 and will grow at a 6.1% CAGR between 2024 and 2032, driven by a high prevalence of hypertension and increased awareness of cardiovascular health. The region benefits from advanced healthcare infrastructure and widespread access to medical technologies, facilitating the adoption of both digital and manual sphygmomanometers.Furthermore, ongoing initiatives to improve chronic disease management and promote preventive healthcare are further boosting demand. With a focus on innovation and quality healthcare, North America will stand as a key contributor to the overall growth of the sphygmomanometer industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of cardiovascular disorders including hypertension
    • 3.2.1.2 Increase in average patient visits in healthcare settings
    • 3.2.1.3 Technological advancements in sphygmomanometers
    • 3.2.1.4 Growing geriatric population pool
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory approvals and compliance
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing analysis, 2023
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Digital sphygmomanometer
  • 5.2.1 Arm electronic sphygmomanometer
  • 5.2.2 Wrist electronic sphygmomanometer
• 5.3 Aneroid sphygmomanometer
• 5.4 Mercury sphygmomanometer

Chapter 6 Market Estimates and Forecast, By Operation, 2021 - 2032 ($ Mn and Units)

• 6.1 Key trends
• 6.2 Manual
• 6.3 Automatic
• 6.4 Semi-automatic

Chapter 7 Market Estimates and Forecast, By Configuration, 2021 - 2032 ($ Mn and Units)

• 7.1 Key trends
• 7.2 Portable
• 7.3 Desk mounted
• 7.4 Floor standing
• 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn and Units)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Homecare
• 8.4 Ambulatory surgical centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 A&D Company, Limited
• 10.2 ACCOSON
• 10.3 American Diagnostic Corporation
• 10.4 Beurer GmbH
• 10.5 Bosch + Sohn GmbH & Co. KG
• 10.6 BPL Medical Technologies Pvt. Ltd.
• 10.7 GE Healthcare
• 10.8 Little Doctor International (S) Pte. Ltd.
• 10.9 Microlife Corporation
• 10.10 Omron Healthcare, Inc.
• 10.11 Prestige Medical
• 10.12 Rudolf Riester GmbH
• 10.13 Rossmax International Ltd.
• 10.14 Spengler SAS
• 10.15 SunTech Medical, Inc.